MSET Share Price Performance
CA$0
0.00 (0.00%)
Sorry, there is currently no price data for this company.
MSET Community Narratives
There are no narratives available yet.
Recent MSET News & Updates
No updates
Mindset Pharma Inc. Key Details
Last Reported Earnings
Mar 31, 2023
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.06
- Gross Margin
- 100.00%
- Net Profit Margin
- -78.82%
- Debt/Equity Ratio
- 0%
Mindset Pharma Inc. Competitors
About MSET
- Founded
- n/a
- Employees
- n/a
- CEO
- WebsiteView website
Mindset Pharma Inc. develops and sells psychedelic medicines to treat neurological and psychiatric disorders in Canada. It focuses on developing MSP-1014, a psychedelic drug candidate. The company is based in Toronto, Canada.
Canadian Market Performance
- 7 Days: 0.4%
- 3 Months: 8.1%
- 1 Year: 23.0%
- Year to Date: 10.4%
The Materials sector gained 6.0% while the market remained flat over the last week. As for the longer term, the market has risen 23% in the past 12 months. Looking forward, earnings are forecast to grow by 12% annually. Market details ›
This week, we are weighing up the potential productivity gains vs job losses and economic disruption that the global economy could face over the next decade and beyond.
Continue reading